Status:
RECRUITING
A Text Messaging Intervention to Reduce Perinatal Depression Risk
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
Yale University
Michigan State University
Conditions:
Major Depressive Episode
Eligibility:
FEMALE
16-45 years
Phase:
NA
Brief Summary
Development and preliminary testing of a text messaging intervention that will reduce the risk of a major depressive episode and worsening depressive symptoms in perinatal individuals. The system will...
Detailed Description
About 1 in 7 pregnant individuals experience depression, with roughly the same number facing this devastating illness after delivery. The downstream effects of perinatal depression adds to its toll wi...
Eligibility Criteria
Inclusion
- English speaking
- "At risk" as determined by an Edinburgh Postnatal Depression Scale score of at least 9, or an average score \>3 on the 6-item Medical Outcomes Social Support Survey or history of depression in pregnancy or postpartum depression
- At least age 16
- Are willing and able to provide informed consent
- Are willing to use a smart phone to receive texts
Exclusion
- In a major depressive episode
- Planning on terminating pregnancy
- Have panic disorder or substance use disorder
- Currently in behavioral health care treatment
- Blind individuals
- Permanently living in an institutional setting
Key Trial Info
Start Date :
September 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06117397
Start Date
September 5 2024
End Date
December 1 2025
Last Update
July 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMass Chan Medical School
Worcester, Massachusetts, United States, 01655